Found: 13
Select item for more details and to access through your institution.
Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 5, p. 474, doi. 10.3390/ph14050474
- By:
- Publication type:
- Article
Effects of CX3CL1 inhibition on murine bleomycin-induced interstitial pneumonia.
- Published in:
- European Journal of Inflammation, 2020, p. 1, doi. 10.1177/2058739220959903
- By:
- Publication type:
- Article
Anti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1821, doi. 10.3390/ijms20081821
- By:
- Publication type:
- Article
Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1173, p. 350, doi. 10.1111/j.1749-6632.2009.04738.x
- By:
- Publication type:
- Article
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases.
- Published in:
- ImmunoTargets & Therapy, 2020, v. 9, p. 241, doi. 10.2147/ITT.S277991
- By:
- Publication type:
- Article
Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1923, doi. 10.1002/art.41009
- By:
- Publication type:
- Article
Role of Anti‐Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental Arthritis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 2, p. 222, doi. 10.1002/art.40688
- By:
- Publication type:
- Article
Blockade of the fractalkine–CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
- Published in:
- International Immunology, 2019, v. 31, n. 5, p. 287, doi. 10.1093/intimm/dxz006
- By:
- Publication type:
- Article
Blockade of the fractalkine–CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
- Published in:
- International Immunology, 2019, v. 31, n. 5, p. 357, doi. 10.1093/intimm/dxz035
- By:
- Publication type:
- Article
Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04420-4
- By:
- Publication type:
- Article
Effects of CX3CL1 inhibition on murine bleomycin-induced interstitial pneumonia.
- Published in:
- European Journal of Inflammation, 2020, v. 18, p. 1, doi. 10.1177/2058739220959903
- By:
- Publication type:
- Article
The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival.
- Published in:
- JBMR Plus, 2022, v. 6, n. 10, p. 1, doi. 10.1002/jbm4.10680
- By:
- Publication type:
- Article
The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival.
- Published in:
- JBMR Plus, 2022, v. 6, n. 10, p. 1, doi. 10.1002/jbm4.10680
- By:
- Publication type:
- Article